Imagine a world where cows are naturally resistant to devastating diseases like avian flu. Sounds like science fiction? Think again. Dr. Bonnie Mallard, a pioneering researcher at the University of Guelph, has developed a groundbreaking technology that’s turning this vision into reality. Her High Immune Response (HIR™) technology is revolutionizing animal health, and it’s already making waves in the fight against avian flu.
But here’s where it gets even more fascinating: HIR™ isn’t just about treating diseases—it’s about preventing them at the genetic level. By identifying animals with naturally strong immune systems and breeding them, Mallard’s technology creates offspring that are inherently more resilient. And this is the part most people miss: these animals don’t just survive better—they thrive. They grow faster, live longer, and require fewer medications, saving farmers significant costs while improving animal welfare.
Mallard’s journey began over 35 years ago during her undergraduate studies. While researching horses with a genetic immune disorder, she had a revelation: if genetic defects can cause illness, could strong immune genetics lead to disease resistance? This simple yet profound question led to decades of research, culminating in HIR™ technology. Today, farmers use antigen test kits to identify high-immune responders, breeding them to strengthen entire herds over generations.
Licensed to Semex, HIR™ has already produced remarkable results. Immunity+® semen, derived from this technology, has created offspring that are half as likely to develop infectious diseases, respond better to vaccines, and produce higher-quality colostrum. These animals also grow faster and live longer, saving farmers hundreds of dollars per animal annually. With millions in revenue generated, HIR™ is one of the University of Guelph’s most profitable patents.
But here’s the controversial part: Can this technology truly prevent the need for drastic measures like culling infected animals? Mallard believes so. She points to the recent avian flu outbreak in U.S. dairy cows, where Immunity+ females showed surprising resilience to H5N1. A study published in the Journal of Dairy Science Communications found that cows with high Immunity+ breeding values were 24% less likely to require treatment after exposure to avian flu. Even more striking, these cows experienced significantly fewer milk production losses, saving farmers an average of $504 USD per affected animal.
And this is where it gets thought-provoking: While vaccines are being developed to combat avian flu, Mallard’s technology offers a complementary approach by creating naturally resistant animals. “If we think the border will stop avian flu from reaching Canadian cattle, we’re wrong,” Mallard warns. “But our study shows that animals bred for better health genetics will be better prepared to fight the disease.”
Now, Mallard is expanding HIR™ to new species, including companion animals, sheep, turkeys, and beef cattle. For instance, beef cattle transported long distances often face diseases like shipping fever pneumonia. By partnering with organizations like the Canadian Angus Association and Hendrix Genetics, Mallard is uncovering genetic clues to protect these animals. Even ostriches, which faced controversial culling during a recent avian flu outbreak, could benefit from this technology.
Mallard’s work has earned her Canada’s top research awards, including the Governor General’s Award for Innovation and the NSERC Synergy Prize. She credits the University of Guelph’s Research Innovation Office and partners like Semex for helping bring her technology to market. “For a university professor, having a good business partner is crucial,” she says. “Semex has been instrumental in this journey.”
Her story also highlights the power of mentorship. As a student, Mallard’s supervisor, Dr. Ted Burnside, introduced her to Semex’s CEO, Dr. Moe Freeman. That meeting led to immediate funding—what Mallard calls “the speed of trust.”
So, here’s the question for you: As we face growing challenges like avian flu and antibiotic resistance, could genetic solutions like HIR™ be the key to sustainable agriculture? Or do we need to tread carefully with such powerful technologies? Let’s start the conversation—share your thoughts in the comments below!
